1. Home
  2. JZ vs PHIO Comparison

JZ vs PHIO Comparison

Compare JZ & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

HOLD

Current Price

$1.02

Market Cap

12.1M

Sector

Real Estate

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.13

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JZ
PHIO
Founded
2011
2011
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
12.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
JZ
PHIO
Price
$1.02
$1.13
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.67
AVG Volume (30 Days)
32.7K
373.2K
Earning Date
10-16-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,589,020.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.97
52 Week High
$14.60
$9.79

Technical Indicators

Market Signals
Indicator
JZ
PHIO
Relative Strength Index (RSI) 36.03 44.78
Support Level $0.98 $1.12
Resistance Level $1.25 $1.22
Average True Range (ATR) 0.12 0.06
MACD -0.00 0.02
Stochastic Oscillator 17.50 52.00

Price Performance

Historical Comparison
JZ
PHIO

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: